Vaccine
Vaccine
  • Clinical Insights

Preparing for the COVID-19 Vaccine

Dec 22nd, 2020

Learn How Your Organization Can Prepare for the COVID-19 Vaccine

Click above to read the guide.

As of mid-December 2020, more than 72 million cases of COVID-19 have been recorded worldwide, leading to over 1.6 million deaths.

The development of effective vaccines against the SARS-CoV-2 virus, which causes COVID-19, has been anxiously anticipated since the onset of the pandemic, and the recent distribution of two vaccines brings hope to—and questions from—health care organizations.

Health care organizations, including long-term care facilities and behavioral health centers, are closely monitoring the development and distribution of vaccines. On their minds: protecting both their front-line health care workers and their consumers, many of them living with chronic, complex health conditions.

Read this guide to learn about the status of the most promising vaccines in development or currently available, and how and when distribution is likely to occur.

Recent Posts


  • Clinical Insights
  • Treatment
Long-acting injectables in practice: What providers need to know

Genoa Healthcare recently hosted a webinar where Senior Product Manager Blake Shoemaker, PharmD, discussed long-acting injectables (LAIs) in practice. Watch the recording below for an overview on benefits, challenges and...

  • Behavioral Health
  • Clinical Insights
  • Treatment
Why medication-assisted treatment is essential for improving patient outcomes

1. Methadone and buprenorphine reduce risk of death after opioid overdose. (2018, June 19). NIH. 2. Methadone and buprenorphine reduce risk of death after opioid overdose. (2018, June 19). NIH....

  • 340B
Your questions, answered: 340B manufacturer pricing restrictions

Drug manufacturers began implementing restrictions for 340B pricing in 2020, citing alleged misuse by safety-net providers and explosive growth of the 340B Drug Pricing Program. Since then, restrictions for the...

  • Behavioral Health
  • Clinical Insights
  • Treatment
Currently available and emerging therapy options for treatment-resistant depression

Studies show that 50% of people with major depressive disorder don’t respond adequately to initial antidepressant treatment.1 Additionally, an estimated 30% of people with major depressive disorder (MDD) experience treatment-resistant...